ETNB - 89bio Inc Stock Price, Fair Value and News

$14.84

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ETNB Price Action

Last 7 days

0.2%

Last 30 days

0.6%

Last 90 days

54.2%

Trailing 12 Months

90.4%

ETNB RSI Chart

ETNB Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

-4.89

Price/Sales (Trailing)

627.77

EV/EBITDA

-4.76

Price/Free Cashflow

-3.09

ETNB Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ETNB Fundamentals

ETNB Revenue

Revenue (TTM)

2.2M

ETNB Earnings

Earnings (TTM)

-450.2M

Earnings Growth (Yr)

-132.44%

Earnings Growth (Qtr)

-56.44%

ETNB Profitability

EBT Margin

-20741.91%

Return on Equity

-86.29%

Return on Assets

-74.6%

Free Cashflow Yield

-32.32%

ETNB Investor Care

Shares Dilution (1Y)

40.03%

Diluted EPS (TTM)

-3.66

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2022	652.0K	1.2M	1.7M	2.2M
2021	0	0	0	148.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About 89bio Inc

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.

CEO	Mr. Rohan Palekar
WEBSITE	89bio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	45

89bio Inc Frequently Asked Questions

What is the ticker symbol for 89bio Inc? What does ETNB stand for in stocks?

ETNB is the stock ticker symbol of 89bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of 89bio Inc (ETNB)?

As of Thu Oct 30 2025, market cap of 89bio Inc is 2.2 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ETNB stock?

You can check ETNB's fair value in chart for subscribers.

Is 89bio Inc a good stock to buy?

The fair value guage provides a quick view whether ETNB is over valued or under valued. Whether 89bio Inc is cheap or expensive depends on the assumptions which impact 89bio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ETNB.

What is 89bio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Oct 30 2025, ETNB's PE ratio (Price to Earnings) is -4.89 and Price to Sales (PS) ratio is 627.77. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ETNB PE ratio will change depending on the future growth rate expectations of investors.